Ittero Therapeutics

Our mission is to develop novel disease modifying medicines for rare CNS genetic diseases caused by trinucleotide repeat expansion mutations

  • Stage Product In Development
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency USD
  • Founded December 2019
  • Employees 0
  • Incorporation Type C-corp
  • Website itterotx.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free